Chapter 1.Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Rare Disease Generic Testing Market , by Region, 2019-2027 (USD Billion)
1.2.2. Rare Disease Generic Testing Market , by Disease Type, 2019-2027 (USD Billion)
1.2.3. Rare Disease Generic Testing Market , by Technology Outlook, 2019-2027 (USD Billion)
1.2.4. Rare Disease Generic Testing Market , by Speciality Outlook, 2019-2027 (USD Billion)
1.2.5. Rare Disease Generic Testing Market , by End use Outlook, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Rare Disease Generic Testing Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Rare Disease Generic Testing Market Dynamics
3.1. Rare Disease Generic Testing Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. The need for an accurate and timely diagnosis for rare conditions
3.1.2. Market Challenges
3.1.2.1. Lack of awareness about the diseases and its underlying effects
3.1.3. Market Opportunities
3.1.3.1. Technological advancements in data collection and interpretation for clinical practice
Chapter 4. Global Rare Disease Generic Testing Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Rare Disease Generic Testing Market , by Disease Type
5.1. Market Snapshot
5.2. Global Rare Disease Generic Testing Market by Disease Type, Performance - Potential Analysis
5.3. Global Rare Disease Generic Testing Market Estimates & Forecasts by Disease Type 2018-2027 (USD Billion)
5.4. Rare Disease Generic Testing Market , Sub Segment Analysis
5.4.1. Neurological Disorders,
5.4.2. Immunological Disorders,
5.4.3. Hematology Diseases,
5.4.4. Endocrine & Metabolism Diseases,
5.4.5. Cancer,
5.4.6. Musculoskeletal Disorders,
5.4.7. Cardiovascular Disorders,
5.4.8. Dermatology Diseases,
5.4.9. Other Rare Diseases
Chapter 6. Global Rare Disease Generic Testing Market , by Technology Outlook
6.1. Market Snapshot
6.2. Global Rare Disease Generic Testing Market by Technology Outlook, Performance - Potential Analysis
6.3. Global Rare Disease Generic Testing Market Estimates & Forecasts by Technology Outlook 2018-2027 (USD Billion)
6.4. Rare Disease Generic Testing Market , Sub Segment Analysis
6.4.1. Next Generation Sequencing
6.4.2. Array Technology
6.4.3. PCR - based Testing
6.4.4. FISH
6.4.5. Sanger Sequencing
6.4.6. Karyotyping
Chapter 7. Global Rare Disease Generic Testing Market , by Speciality Outlook
7.1. Market Snapshot
7.2. Global Rare Disease Generic Testing Market by Speciality Outlook, Performance - Potential Analysis
7.3. Global Rare Disease Generic Testing Market Estimates & Forecasts by Speciality Outlook 2018-2027 (USD Billion)
7.4. Rare Disease Generic Testing Market , Sub Segment Analysis
7.4.1. Molecular Genetic Tests
7.4.2. Chromosomal Genetic Tests
7.4.3. Biochemical Genetic Tests
Chapter 8. Global Rare Disease Generic Testing Market , by End use Outlook
8.1. Market Snapshot
8.2. Global Rare Disease Generic Testing Market by End use Outlook, Performance - Potential Analysis
8.3. Global Rare Disease Generic Testing Market Estimates & Forecasts by End use Outlook 2018-2027 (USD Billion)
8.4. Rare Disease Generic Testing Market , Sub Segment Analysis
8.4.1. Research Laboratories & CROs,
8.4.2. Hospitals & Clinics,
8.4.3. Diagnostic Laboratories



Chapter 9. Global Rare Disease Generic Testing Market , Regional Analysis
9.1. Rare Disease Generic Testing Market , Regional Market Snapshot
9.2. North America Rare Disease Generic Testing Market
9.2.1. U.S. Rare Disease Generic Testing Market
9.2.1.1. Disease Type breakdown estimates & forecasts, 2018-2027
9.2.1.2. Technology Outlook breakdown estimates & forecasts, 2018-2027
9.2.1.3. Speciality Outlook breakdown estimates & forecasts, 2018-2027
9.2.1.4. End Use Outlook breakdown estimates & forecasts, 2018-2027
9.2.2. Canada Rare Disease Generic Testing Market
9.3. Europe Rare Disease Generic Testing Market Snapshot
9.3.1. U.K. Rare Disease Generic Testing Market
9.3.2. Germany Rare Disease Generic Testing Market
9.3.3. France Rare Disease Generic Testing Market
9.3.4. Spain Rare Disease Generic Testing Market
9.3.5. Italy Rare Disease Generic Testing Market
9.3.6. Rest of Europe Rare Disease Generic Testing Market
9.4. Asia-Pacific Rare Disease Generic Testing Market Snapshot
9.4.1. China Rare Disease Generic Testing Market
9.4.2. India Rare Disease Generic Testing Market
9.4.3. Japan Rare Disease Generic Testing Market
9.4.4. Australia Rare Disease Generic Testing Market
9.4.5. South Korea Rare Disease Generic Testing Market
9.4.6. Rest of Asia Pacific Rare Disease Generic Testing Market
9.5. Latin America Rare Disease Generic Testing Market Snapshot
9.5.1. Brazil Rare Disease Generic Testing Market
9.5.2. Mexico Rare Disease Generic Testing Market
9.6. Rest of The World Rare Disease Generic Testing Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Quest Diagnostics Inc
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Centogene N.V.
10.2.3. Invitae Corporation
10.2.4. 3billion, Inc.
10.2.5. Arup Laboratories
10.2.6. Eurofins Scientific
10.2.7. Strand Life Sciences
10.2.8. Ambry Genetics
10.2.9. Perkin Elmer, Inc.
10.2.10. Macrogen, Inc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption